Nachweis ossärer metastasen des prostatakarzinoms - Vergleich der leistungsfähigkeit der ganzkörper-mrt und der skelettszintigrafie

Translated title of the contribution: Detection of bone metastasis of prostate cancer - Comparison of whole-body mri and bone scintigraphy

Dominik Ketelsen*, M. Röthke, P. Aschoff, A. S. Merseburger, M. P. Lichy, M. Reimold, C. D. Claussen, H. P. Schlemmer

*Corresponding author for this work
31 Citations (Scopus)


Purpose: Prostate cancer continues to be the third leading cancer-related mortality of western men. Early diagnosis of bone metastasis is important for the therapy regime and for assessing the prognosis. The standard method is bone scintigraphy. Whole-body MRI proved to be more sensitive for early detection of skeletal metastasis. However, studies of homogenous tumor entities are not available. The aim of the study was to compare bone scintigraphy and whole-body MRI regarding the detection of bone metastasis of prostate cancer. Materials and Methods: 14 patients with histologically confirmed prostate cancer and a bone scintigraphy as well as whole-body MRI within one month were included. The mean age was 68 years. Scintigraphy was performed using the planar whole-body technique (ventral and dorsal projections). Suspect areas were enlarged. Wholebody MRI was conducted using native T1w and STIR sequences in the coronary plane of the whole body, sagittal imaging of spine and breath-hold STIR and T1w-Flash-2D sequences of ribs and chest. Bone scintigraphy and whole-body MRI were evaluated retrospectively by experienced radiologists in a consensus reading on a lesion-based level. Results: Whole-body MRI detected significantly more bone metastasis (p = 0.024). 96.4% of the demonstrated skeletal metastases in bone scintigraphy were founded in whole-body MRI while only 58.6% of the depicted metastases in MRI were able to be located in scintigraphy. There was no significant difference regarding bone metastasis greater than one centimeter (p = 0.082) in contrast to metastasis less than one centimeter (p = 0.035). Small osteoblastic metastases showed a considerably higher contrast in T1w sequences than in STIR imaging. Further advantages of whole-body MRI were additional information about extra-osseous tumor infiltration and their complications, for example stenosis of spinal canal or vertebral body fractures, found in 42.9% of patients. Conclusion: Whole-body MRI using native STIR and T1w sequences is superior to bone scintigraphy for the detection of small bone metastasis of prostate cancer. Simultaneous clarification of associated complications demonstrates further advantages.

Translated title of the contributionDetection of bone metastasis of prostate cancer - Comparison of whole-body mri and bone scintigraphy
Original languageGerman
JournalRoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren
Issue number8
Pages (from-to)746-752
Number of pages7
Publication statusPublished - 08.2008

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)


Dive into the research topics of 'Detection of bone metastasis of prostate cancer - Comparison of whole-body mri and bone scintigraphy'. Together they form a unique fingerprint.

Cite this